Aminocaproic acid
- Generic Name
- Aminocaproic acid
- Brand Names
- Amicar
- Drug Type
- Small Molecule
- Chemical Formula
- C6H13NO2
- CAS Number
- 60-32-2
- Unique Ingredient Identifier
- U6F3787206
- Background
An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
- Indication
For use in the treatment of excessive postoperative bleeding.
- Associated Conditions
- Hemorrhage
Tranexamic Acid (TXA) Versus Epsilon Aminocaproic Acid (EACA) Versus Placebo for Spine Surgery
Phase 4
Completed
- Conditions
- Scoliosis
- Interventions
- First Posted Date
- 2009-08-13
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 177
- Registration Number
- NCT00958581
- Locations
- 🇺🇸
New York University School of Medicine - Department of Orthopaedic Surgery - Spine, New York, New York, United States
Amicar Pharmacokinetics of Children Having Craniofacial Surgery
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- Paul Stricker
- Target Recruit Count
- 18
- Registration Number
- NCT00912119
- Locations
- 🇺🇸
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Effects of Aprotinin During Cardiac Surgery/Long Term Death Rates
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2016-04-19
- Lead Sponsor
- State University of New York - Upstate Medical University
- Target Recruit Count
- 462
- Registration Number
- NCT00617955
- Locations
- 🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass
Phase 2
Completed
- Conditions
- FibrinolysisCardiopulmonary BypassInflammationSurgery
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-11-25
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 150
- Registration Number
- NCT00223704
- Locations
- 🇺🇸
TN Valley Healthcare System, Nashville, Tennessee, United States
🇺🇸Vanderbilt University, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath